Talazoparib
Back to searchMolecule Structure
Scientific Name
Talazoparib
Description of the Drug
Talazoparib is a poly-ADP ribose polymerase inhibitor used to treat HER2-, BRCA mutated locally advanced or metastatic breast cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11760
http://www.drugbank.ca/drugs/DB11760
Brand Name(s)
Not Available
Company Owner(s)
Pfizer Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Poly [ADP-ribose] polymerase-1 | SINGLE PROTEIN | INHIBITOR | CHEMBL3105 |
| Poly [ADP-ribose] polymerase 2 | SINGLE PROTEIN | INHIBITOR | CHEMBL5366 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2299348 | ||
| DrugBank | DB11760 | ||
| PubChem: Thomson Pharma | 89447774 | ||
| PubChem | 135565082 | ||
| Nikkaji | J3.353.317I | ||
| PDBe | 2YQ | ||
| BindingDB | 50084621 | ||
| DrugCentral | 5300 | ||
| ChemicalBook | CB22615112 | ||
| rxnorm | TALZENNA | TALAZOPARIB | TALAZOPARIB TOSYLATE |
| ZINC | ZINC000072318110 |
